Microbiotica Wins Biotech And Money’s "Life Science Spin-Out Of The Year"
Published: Sep 18, 2017
Cambridge, UK, 18 September 2018 – Microbiotica, a leading player in microbiome-based therapeutics, announces that it was chosen as the winner of the ‘Life Science Spin-out of the Year’ at the recent Biotech and Money 2017 Awards.
The award recognises both Microbiotica’s potential in the microbiome sector and its achievements to date as the newest spin-out company from the world-renowned Wellcome Trust Sanger Institute, including its £8m equity financing in 2016 from Cambridge Innovation Capital and IP Group. The Company is at the forefront of understanding how the microbiome can be used to develop new therapeutics for a range of diseases and to stratify patients according to their microbiata.